Avexitide

DRUG3 trials

Sponsors

Dr. Tracey McLaughlin, MD, Amylyx Pharmaceuticals Inc.

Conditions

Acquired Hyperinsulinemic HypoglycemiaPost Bariatric HypoglycemiaPost-bariatric Hypoglycemia

Phase 2

Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia

CompletedNCT04652479

Dr. Tracey McLaughlin, MDAcquired Hyperinsulinemic Hypoglycemia

Start: 2021-06-21End: 2022-06-30Updated: 2023-06-09

Phase 3

Avexitide for Treatment of Post-Bariatric Hypoglycemia

Active, not recruitingNCT06747468

Amylyx Pharmaceuticals Inc.Post Bariatric Hypoglycemia

Start: 2025-04-29End: 2027-02-01Target: 75Updated: 2026-08-24

Unknown Phase

An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals Inc.Post-bariatric Hypoglycemia

Updated: 2026-07-14

Related Papers

Efficacy and safety of avexitide for treatment of hypoglycemia following bariatric and other upper gastrointestinal surgeries: a phase 2b study.

2026-09-15

OR03-4 Efficacy and Safety of Avexitide for Treatment of Hypoglycemia after Gastrointestinal Surgery; Assessment of Novel Dosing Regimens in an Expanded Indication

Journal of the Endocrine Society2022-11-01